Influence of memantine on nociceptive responses of the trigeminocervical complex after formalin injection

Cephalalgia

Volumn 32, Issue 4, 2012, Pages 308-316

  Park, Jeong Wook ^a   Suh, Gyoung Im ^a   Shin, Hae Eun ^a   Park, Go Eun ^a  

^a Uijeongbu St Mary's Hospital   (South Korea)

Author keywords

formalin; Fos; headache; Trigeminal system; trigeminocervical complex

Indexed keywords

FORMALDEHYDE; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN FOS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CONTROLLED STUDY; DERMATOME; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NOCICEPTION; NONHUMAN; PAIN THRESHOLD; RAT; STIMULUS RESPONSE;

ANIMALS; EXCITATORY AMINO ACID ANTAGONISTS; FORMALDEHYDE; IMMUNOHISTOCHEMISTRY; IRRITANTS; MALE; MEMANTINE; OPHTHALMIC NERVE; PAIN; PAIN THRESHOLD; RATS; RATS, SPRAGUE-DAWLEY; TRIGEMINAL NERVE;

EID: 84863376049     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102411435986     Document Type: Article

References (64)

1. Kew JN, Kemp JA. Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology (Berl). 2005 ; 179: 4-29 (Pubitemid 40576690)
2. Andreou AP, Goadsby PJ. Therapeutic potential of novel glutamate receptor antagonists in migraine. Expert Opin Investig Drugs. 2009 ; 18: 789-803
3. Haley JE, Sullivan AF, Dickenson AH. Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat. Brain Res. 1990 ; 518: 218-226 (Pubitemid 20197052)
4. Hudspith MJ, Harrisson S, Smith G, Bountra C, Elliot PJ, Birch PJ, et al. Effect of post-injury NMDA antagonist treatment on long-term Fos expression and hyperalgesia in a model of chronic neuropathic pain. Brain Res. 1999 ; 822: 220-227 (Pubitemid 29222845)
5. Munglani R, Hudspith MJ, Fleming B, Harrisson S, Smith G, Bountra C, et al. Effect of pre-emptive NMDA antagonist treatment on long-term Fos expression and hyperalgesia in a model of chronic neuropathic pain. Brain Res. 1999 ; 822: 210-219 (Pubitemid 29222844)
6. Zhou S, Bonasera L, Carlton SM. Peripheral administration of NMDA, AMPA or KA results in pain behaviors in rats. Neuroreport. 1996 ; 7: 895-900 (Pubitemid 26167972)
7. Allen RM, Dykstra LA. N-methyl-D-aspartate receptor antagonists potentiate the antinociceptive effects of morphine in squirrel monkeys. J Pharmacol Exp Ther. 2001 ; 298: 288-297 (Pubitemid 32574539)
8. Bespalov A, Kudryashova M, Zvartau E. Prolongation of morphine analgesia by competitive NMDA receptor antagonist D-CPPene (SDZ EAA 494) in rats. Eur J Pharmacol. 1998 ; 351: 299-305 (Pubitemid 28321465)
9. Grass S, Hoffmann O, Xu XJ, Wiesenfeld-Hallin Z. N-methyl-D-aspartate receptor antagonists potentiate morphine's antinociceptive effect in the rat. Acta Physiol Scand. 1996 ; 158: 269-273 (Pubitemid 26361811)
10. Greenamyre JT, Young AB, Penney JB. Quantitative autoradiographic distribution of L-[3H]glutamate-binding sites in rat central nervous system. J Neurosci. 1984 ; 4: 2133-2144 (Pubitemid 14025574)
11. Kai-Kai MA, Howe R. Glutamate-immunoreactivity in the trigeminal and dorsal root ganglia, and intraspinal neurons and fibres in the dorsal horn of the rat. Histochem J. 1991 ; 23: 171-179
12. Tallaksen-Greene SJ, Young AB, Penney JB, Beitz AJ. Excitatory amino acid binding sites in the trigeminal principal sensory and spinal trigeminal nuclei of the rat. Neurosci Lett. 1992 ; 141: 79-83
13. Broman J, Ottersen OP. Cervicothalamic tract terminals are enriched in glutamate-like immunoreactivity: an electron microscopic double-labeling study in the cat. J Neurosci. 1992 ; 12: 204-221
14. Phencyclidine: a drug of abuse and a tool for neuroscience research. Balster RL Willetts J, ed. Berlin: Springer-Verlag ; 1996 :
15. Mothet JP, Parent AT, Wolosker H, Brady RO, Linden DJ, Ferris CD, et al. D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A. 2000 ; 97: 4926-4931 (Pubitemid 30238659)
16. Medvedev IO, Malyshkin AA, Belozertseva IV, Sukhotina IA, Sevostianova NY, Aliev K, et al. Effects of low-affinity NMDA receptor channel blockers in two rat models of chronic pain. Neuropharmacology. 2004 ; 47: 175-183 (Pubitemid 38824641)
17. Storer RJ, Goadsby PJ. Trigeminovascular nociceptive transmission involves N-methyl-D-aspartate and non-N-methyl-D-aspartate glutamate receptors. Neuroscience. 1999 ; 90: 1371-1376 (Pubitemid 29170152)
18. Eisenberg E, LaCross S, Strassman AM. The clinically tested N-methyl-D-aspartate receptor antagonist memantine blocks and reverses thermal hyperalgesia in a rat model of painful mononeuropathy. Neurosci Lett. 1995 ; 187: 17-20
19. Eisenberg E, Vos BP, Strassman AM. The NMDA antagonist memantine blocks pain behavior in a rat model of formalin-induced facial pain. Pain. 1993 ; 54: 301-307 (Pubitemid 23259289)
20. Bigal M, Rapoport A, Sheftell F, Tepper D, Tepper S. Memantine in the preventive treatment of refractory migraine. Headache. 2008 ; 48: 1337-1342
21. Dickenson AH, Sullivan AF. Subcutaneous formalin-induced activity of dorsal horn neurones in the rat: differential response to an intrathecal opiate administered pre or post formalin. Pain. 1987 ; 30: 349-360 (Pubitemid 18028132)
22. Duale C, Luccarini P, Cadet R, Woda A. Effects of morphine microinjections into the trigeminal sensory complex on the formalin test in the rat. Exp Neurol. 1996 ; 142: 331-339 (Pubitemid 26414065)
23. Raboisson P, Dallel R. The orofacial formalin test. Neurosci Biobehav Rev. 2004 ; 28: 219-226 (Pubitemid 38692365)
24. Morgan JI, Curran T. Stimulus-transcription coupling in neurons: role of cellular immediate-early genes. Trends Neurosci. 1989 ; 12: 459-462 (Pubitemid 19259026)
25. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994 ; 53: 55-63 (Pubitemid 24238751)
26. Vos BP, Strassman AM, Maciewicz RJ. Behavioral evidence of trigeminal neuropathic pain following chronic constriction injury to the rat's infraorbital nerve. J Neurosci. 1994 ; 14: 2708-2723 (Pubitemid 24140897)
27. Benjamin L, Levy MJ, Lasalandra MP, Knight YE, Akerman S, Classey JD, et al. Hypothalamic activation after stimulation of the superior sagittal sinus in the cat: a Fos study. Neurobiol Dis. 2004 ; 16: 500-505 (Pubitemid 38942982)
28. The rat brain in stereotaxic coordinates. 2 nd edn. London: Academic Press, 2003. Paxinos G Franklin KBJ, ed. London: Academic Press ; 2003 :
29. Siegel S Non-parametric Statistics for the Behavioural Sciences. Kogakusha, Tokyo: McGraw-Hill ; 1956 :
30. Mitsikostas DD, Sanchez del Rio M. Receptor systems mediating c-fos expression within trigeminal nucleus caudalis in animal models of migraine. Brain Res Brain Res Rev. 2001 ; 35: 20-35 (Pubitemid 32203700)
31. Potrebic S, Ahn AH, Skinner K, Fields HL, Basbaum AI. Peptidergic nociceptors of both trigeminal and dorsal root ganglia express serotonin 1D receptors: implications for the selective antimigraine action of triptans. J Neurosci. 2003 ; 23: 10988-10997 (Pubitemid 37499709)
32. Hoskin KL, Bulmer DC, Goadsby PJ. Fos expression in the trigeminocervical complex of the cat after stimulation of the superior sagittal sinus is reduced by L-NAME. Neurosci Lett. 1999 ; 266: 173-176 (Pubitemid 29249243)
33. Classey JD, Knight YE, Goadsby PJ. The NMDA receptor antagonist MK-801 reduces Fos-like immunoreactivity within the trigeminocervical complex following superior sagittal sinus stimulation in the cat. Brain Res. 2001 ; 907: 117-124 (Pubitemid 32595518)
34. Bergerot A, Storer RJ, Goadsby PJ. Dopamine inhibits trigeminovascular transmission in the rat. Ann Neurol. 2007 ; 61: 251-262 (Pubitemid 46557349)
35. Burstein R, Cutrer MF, Yarnitsky D. The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain. 2000 ; 123: 1703-1709 (Pubitemid 30481193)
36. Burstein R, Yamamura H, Malick A, Strassman AM. Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol. 1998 ; 79: 964-982 (Pubitemid 28095912)
37. Goadsby PJ. Migraine, allodynia, sensitisation and all of that. Eur Neurol. 2005 ; 53 (Suppl 1). 10-16 (Pubitemid 40827680)
38. Goadsby PJ. The 'Act when Mild' (AwM) study: a step forward in our understanding of early treatment in acute migraine. Cephalalgia. 2008 ; 28 (Suppl 2). 36-41
39. Hoskin KL, Zagami AS, Goadsby PJ. Stimulation of the middle meningeal artery leads to Fos expression in the trigeminocervical nucleus: a comparative study of monkey and cat. J Anat. 1999 ; 194: 579-588 (Pubitemid 29335626)
40. Goadsby PJ, Hoskin KL, Knight YE. Substance P blockade with the potent and centrally acting antagonist GR205171 does not effect central trigeminal activity with superior sagittal sinus stimulation. Neuroscience. 1998 ; 86: 337-343 (Pubitemid 28270878)
41. Dubuisson D, Dennis SG. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain. 1977 ; 4: 161-174 (Pubitemid 8234766)
42. Gordon SM, Dionne RA, Brahim J, Jabir F, Dubner R. Blockade of peripheral neuronal barrage reduces postoperative pain. Pain. 1997 ; 70: 209-215 (Pubitemid 27179633)
43. Gottschalk A, Smith DS, Jobes DR, Kennedy SK, Lally SE, Noble VE, et al. Preemptive epidural analgesia and recovery from radical prostatectomy: a randomized controlled trial. JAMA. 1998 ; 279: 1076-1082 (Pubitemid 28177815)
44. Tverskoy M, Oz Y, Isakson A, Finger J, Bradley EL, Kissin I. Preemptive effect of fentanyl and ketamine on postoperative pain and wound hyperalgesia. Anesth Analg. 1994 ; 78: 205-209 (Pubitemid 24055832)
45. Puig S, Sorkin LS. Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activity. Pain. 1996 ; 64: 345-355 (Pubitemid 26132446)
46. Dickenson AH, Sullivan AF. Peripheral origins and central modulation of subcutaneous formalin-induced activity of rat dorsal horn neurones. Neurosci Lett. 1987 ; 83: 207-211 (Pubitemid 18001452)
47. Raboisson P, Dallel R, Clavelou P, Sessle BJ, Woda A. Effects of subcutaneous formalin on the activity of trigeminal brain stem nociceptive neurones in the rat. J Neurophysiol. 1995 ; 73: 496-505
48. Carlton SM, Hargett GL. Treatment with the NMDA antagonist memantine attenuates nociceptive responses to mechanical stimulation in neuropathic rats. Neurosci Lett. 1995 ; 198: 115-118
49. Coderre TJ, Melzack R. The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury. J Neurosci. 1992 ; 12: 3665-3670
50. Parsons CG, Danysz W, Quack G. Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist-a review of preclinical data. Neuropharmacology. 1999 ; 38: 735-767 (Pubitemid 29187336)
51. Hargreaves EL, Cain DP. Hyperactivity, hyper-reactivity, and sensorimotor deficits induced by low doses of the N-methyl-D-aspartate non-competitive channel blocker MK801. Behav Brain Res. 1992 ; 47: 23-33
52. Woolf CJ. Windup and central sensitization are not equivalent. Pain. 1996 ; 66: 105-108 (Pubitemid 26283977)
53. Davies SN, Lodge D. Evidence for involvement of N-methylaspartate receptors in 'wind-up' of class 2 neurones in the dorsal horn of the rat. Brain Res. 1987 ; 424: 402-406 (Pubitemid 18047687)
54. Schneider SP, Perl ER. Comparison of primary afferent and glutamate excitation of neurons in the mammalian spinal dorsal horn. J Neurosci. 1988 ; 8: 2062-2073
55. Dickenson AH, Sullivan AF. Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C fibre stimulation. Neuropharmacology. 1987 ; 26: 1235-1238 (Pubitemid 17123438)
56. Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron. 1994 ; 12: 529-540 (Pubitemid 24100885)
57. Boyce S, Wyatt A, Webb JK, O'Donnell R, Mason G, Rigby M, et al. Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn. Neuropharmacology. 1999 ; 38: 611-623 (Pubitemid 29150316)
58. Kovacs G, Kocsis P, Tarnawa I, Horvath C, Szombathelyi Z, Farkas S. NR2B containing NMDA receptor dependent windup of single spinal neurons. Neuropharmacology. 2004 ; 46: 23-30 (Pubitemid 37494736)
59. Chizh BA, Headley PM, Tzschentke TM. NMDA receptor antagonists as analgesics: focus on the NR2B subtype. Trends Pharmacol Sci. 2001 ; 22: 636-642 (Pubitemid 33135525)
60. Zhuo M. Glutamate receptors and persistent pain: targeting forebrain NR2B subunits. Drug Discov Today. 2002 ; 7: 259-267 (Pubitemid 34144617)
61. Tan PH, Yang LC, Shih HC, Lan KC, Cheng JT. Gene knockdown with intrathecal siRNA of NMDA receptor NR2B subunit reduces formalin-induced nociception in the rat. Gene Ther. 2005 ; 12: 59-66
62. Gurwitz D, Weizman A. The NR2B subunit of glutamate receptors as a potential target for relieving chronic pain: prospects and concerns. Drug Discov Today. 2002 ; 7: 403-406 (Pubitemid 34251104)
63. Lipton SA. Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation. Curr Drug Targets. 2007 ; 8: 621-632 (Pubitemid 46785060)
64. Schneiderman JH. Topiramate: pharmacokinetics and pharmacodynamics. Can J Neurol Sci. 1998 ; 25: S3 - S5